Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 756 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
14 Мб
Скачать
70
https://t.me/med1917
J. Lambert et al.
Prehabilitation: What Does It Mean inHealthcare Contexts?
“Prehabilitation” [1, 2] is a term used to capture interventions to prepare patients for healthcare treatment, typically surgery. Like a marathon, surgery is a huge stressor on the human body and training in the form of prehabilitation prepares the body for this challenge. Prehabilitation interventions typically comprise of exercise, nutri­tion, and psycho-social support [2] but are multi-factorial and even encompass the management of tobacco [3], alcohol [4], and other addictions.
Prehabilitation can improve cardiorespiratory tness before cancer surgery [5], which improves functional capacity and reduces hospital length of stay [2], thus offering patient-centred and economic benets. Indeed, prehabilitation has the potential to reduce the peri-operative risk proles of patients who are deemed unt for major operations. It is generally accepted that reducing complication rates and a quicker return to baseline functional capacity can accelerate the progression of can­cer patients to chemotherapy. Reduced time to chemotherapy has been seen in some cancer cohorts to offer a survival benet [6]. We have yet to identify a prehabilita­tion strategy that works for everyone; and like many exercise interventions [7], there is a heterogenous response to prehabilitation.
What Should Prehabilitation Comprise of?
Exercise
Programmes are designed to improve cardiovascular tness and physiological reserve, to build muscle and improve strength, and augment well-being and psycho­logical resilience. Most exercise programmes comprise of a combination of aerobic and strength training, delivered via a supervised or unsupervised format. This may involve a graded regime where patients complete a form of aerobic training at a percentage of their maximal heart rate, and increase this percentage every week to achieve a specied level of exertion (mild, moderate, or high intensity).
Published data suggests that bespoke supervised exercise interventions outper­form unsupervised formats in achieving exertional intensity and compliance. Breathing exercises have also been suggested as a useful way of improving the function of the muscles of breathing and as a stress-reduction strategy [8].
Patients diagnosed with gastrointestinal (GI) malignancies often present with a series of clinical signs including tiredness, weight loss, anaemia, and jaundice. These signs often coincide with long periods of under-nutrition and deconditioning. The highest frequency of GI malignancy presentation is within the sixth to eighth decades, where sarcopenia may be another compounding factor. Several recent studies have alluded to poor muscle quality and function as an independent predic­tor of adjuvant chemotherapy toxicity, morbidity, and mortality in GI cancer surgery [9, 10].
5 Prehabilitation forGastrointestinal Cancer Surgery
https://t.me/med1917
Diminished Oxidative Stress
There is evidence to suggest that exercise may modulate the tumour micro­environment by reducing pro-inammatory mediators associated with tumour spread [11]. Exercise may play an anti-inammatory role by reducing oxidative stress [12], which may be important in patients undergoing concurrent chemother­apy and radiotherapy treatment. Although the psychological aspects of exercise within prehabilitation have not been extensively studied, there is evidence to sug­gest that exercise may improve psychological resilience peri-operatively [13]. This could be paramount in patients living with indolent or recurrent disease.
Within the clinical context, cardiopulmonary exercise testing (CPET), peak expi­ratory ow rates, and hand grip strength may be used to objectively measure improvements in tness. However, outside clinical trials, these measures are rarely used for this purpose due to cancer target times, resourcing, and scheduling con­straints. The challenge in designing exercise regimes revolves around a protocol that is acceptable in terms of ease of completion and scalability, while also being effec­tive with high compliance and adherence.
71
Nutrition
The main goal of nutrition in prehabilitation is to rst ensure that patients are euca­loric, then aiming to supplement macronutrients and micronutrients guided by a dietician within a multi-disciplinary team (MDT). This process often involves screening using the Malnutrition Universal Screening Tool (MUST), which is com­mon in the UK settings but also used worldwide and based on the most recent European Society of Clinical Nutrition and Metabolism (ESPEN) guidelines . In addition, in patients with malignant biliary obstruction, pancreatic enzyme replace­ment therapy was associated with improved survival [14]. Within clinical practice, it would be benecial to supplement patients as early as possible within their treat­ment pathways, and even prior to enrolment on a formal prehabilitation programme.
Although there is no specic nutrition regime that guarantees caloric goal achievement, carbohydrate, protein, fat, and micronutrient supplementation are commonplace. In GI cancer patients, there is often weight loss directly because of mechanical obstruction and/or malabsorption, and indirectly through tumour wast­ing effects or cachexia, often mediated through cytokine signalling pathways [15].
Commercial Supplements
Several regimes including whey protein [16, 17], fortied protein drinks [18], and amino acid-based compounds [19] have been used in controlled trial settings and more liberally based on hospital protocols. As a standalone measure, the impact of nutrition on outcomes has been difcult to quantify due to the integrated biological
72
https://t.me/med1917
and physiological pathways through which nutrition may exert its effects. Details from prehabilitation trials involving supplementation suggest that timing of inges­tion; usually just prior to or after exercise may be more benecial as this relates to metabolism of substrates, especially regimes focused on building muscle.
The effect of nutrition may be best appreciated when employed within a multi- modal programme due to its synergy with exercise. Various delivery methods such as nasogastric, nasojejunal, and gastrostomy routes may be used in cases where there may be some anatomical anomaly, other gut dysfunction, or where feeding needs to be accelerated. Parenteral feeding is now indicated only in exceptional circumstances given its high costs, substantial morbidity, and inferior benets.
J. Lambert et al.
Psycho-Social Support
Talking therapies and formal counselling, when integrated into multi-modal preha­bilitation programmes, are associated with reduced levels of treatment related stress [20, 21]. As previously mentioned, there appears to be a positive association between exercise and improved well-being/psychological resilience. What is clear from other data concerning psychological challenges in cancer diagnoses in general, is that there may be several interrelated factors (biological, personal, and social) in the way patients perceive and manage illness [22]. Meaningful relationships, family support, baseline health, prior illnesses, and cancer diagnoses all contribute to the way patients may choose to deal with their illness, and their levels of engagement with cancer care teams.
Cessation ofSmoking andAlcohol
It is now universal practice to support patients with nicotine and alcohol dependence by offering advice and interventions to facilitate cessation. These may take the form of pharmacological treatments such as nicotine replacement or psychosocial thera­pies. Smoking cessation may improve patients exercise tolerance and when consid­ered within a prehabilitation exercise programme is likely to improve adherence. Likewise, alcohol dependence is often associated with macronutrient and micronu­trient deciencies that may impact on substrate utilisation and impede the positive adaptive effects following exercise.
While these interventions are likely to work alongside prehabilitation pro­grammes, they are also important public health interventions that have long been established in the promotion of healthier lifestyles. The evidence suggests that smoking cessation for even relatively short durations preoperatively (2 weeks) [23] can reduce morbidity and complications in the peri-opera­tive period.
5 Prehabilitation forGastrointestinal Cancer Surgery
https://t.me/med1917
73
Obesity Reduction
While prehabilitation may provide a platform for patients to adopt more healthy lifestyles postoperatively, in clinical practice, it is often unrealistic to expect consid­erable weight reduction within cancer operative timescales. For this reason, the suc­cess of prehabilitation programmes will inevitably depend on a community-based approach in promoting healthier lifestyles as part of a wider cancer risk reduction strategy.
Management ofOther Medical Conditions andPharmacological Treatments
Other important factors centred around peri-operative care include management of preoperative anaemia, blood glucose, rationalisation of medications, and optimising the treatment of any underlying chronic cardiorespiratory conditions such as atrial brillation, heart failure, and chronic obstructive pulmonary disease (COPD). Within healthcare systems, entire departments have evolved to adopt this important aspect of peri-operative optimisation. They are often given names such as ‘Surgery School’ to focus patients minds as to what they are likely to encounter when referred. In addition to giving procedure specic information, patients are also signposted to resources and support groups, and are given key-worker contact details. This aspect of care is often delivered by a multi-disciplinary team (MDT).
How Long Should Prehabilitation Be?
One of the greatest challenges of prehabilitation is the limited time available to intervene, particularly in circumstances of cancer. Unlike rehabilitation or enhanced recovery after surgery (ERAS) [24] where there are no time pressures, the National Health Service (NHS) in the UK and other world-healthcare bodies have timelines to start treatment, to maximise treatment outcomes. Indeed, prehabilitation should, where possible, not interfere with these timelines and rarely exceeds 31days from a decision to treat. This timescale suggests that ideally one should start prehabilita­tion even before the point of diagnosis.
To manipulate changes in physiological function such as muscle metabolism or cardiorespiratory tness, the minimum period to exert viable improvements is likely 2–4weeks [21, 25]. Smoking and alcohol cessation are likely to complement and enhance the effectiveness of other strategies such as exercise and nutrition. Targets of cardiovascular tness such as anaerobic threshold and peak oxygen consumption can be achieved on a 6-week high intensity exercise programme [26]. In turn, weight reduction in obese patients is likely to take much longer.
74
https://t.me/med1917
J. Lambert et al.
Cancer 4–6Week Protocols
These are average routines, within a wider range. Patients undergoing long-course chemoradiotherapy for advanced rectal cancer have much longer times to partici­pate in prehabilitation programmes, in some cases up to 9weeks [27]. Within clini­cal trial environments, high motivation may inuence the likelihood of completing prehabilitation regimes. In real life, chemo or radiotherapy side-effects preclude participation or completion of programmes, besides time constraints with cancer targets, personal patient factors, and surgery dates. Rather than offer a generic pro­gramme for a large cross-section of patients, resources may have to be targeted to the most ‘at risk’ groups, customised to their needs.
What Protocols are Typically Employed forPrehabilitation?
One author is currently involved in an NIHR study to map prehabilitation services across the UK (NIHR134282). Data collected to date show a wide spectrum of practice ranging from hospitals delivering no formal prehabilitation programmes to established, research-informed, multi-modal prehabilitation offers to most cancer patients. Those that offer prehabilitation programmes often fall into two groups (preoperative interven­tions versus pre- and postoperative interventions). In general, for gastrointestinal cancer surgery, the total time available before surgery is rarely over 9–12weeks, with most being 4–6weeks; this period is often dictated by the type of cancer and whether neoad­juvant therapy is required prior to surgery. Other factors such as correction of anaemia, biliary drainage, and pharmacological optimisation of chronic conditions may also extend the time before surgery and offer a longer window for prehabilitation.
Who Should Deliver Prehabilitation?
The world’s population is ageing such that by 2050, the number of over-60s will nearly double from 12% to 22% [28]. This will further stress healthcare systems across the globe and indeed, in the UK, waiting lists for elective surgery are cur­rently the longest on record with 7.3 million people [29].
Prehabilitation is essential to optimise patient outcomes, but nonetheless, repre­sents an additional burden on top of already stretched healthcare providers such as the NHS.Many prehabilitation programmes are delivered as part of the multi- disciplinary team (MDT) managing a patient’s overall cancer care. The exercise interventions themselves can be delivered by local council gyms, private health clubs, and even football clubs in a local community, harnessing the power of existing infrastructure [30]. Nutrition advice can be delivered in these environments and also inlocal com- munity settings such as you have for weight-loss clubs or similar.
5 Prehabilitation forGastrointestinal Cancer Surgery
https://t.me/med1917
75
Prehabilitation Clinics
These could be delivered by the private sector. They would need to include cardio­pulmonary exercise testing (CPET), dietary analysis, and provision of dietary advice, and access to councillors or clinical psychologists, to ensure the psychologi­cal welfare of those undergoing prehabilitation. There is also the potential to empower patients to undertake prehabilitation themselves, seeking advice from both within and external to the MDT, perhaps including community support groups. This approach does, however, have potential risks. Cancer patients are clinically vulnerable and it’s important that any intervention whether inpatient, outpatient or in the community is research informed, and those delivering any service are appro­priately trained and resourced to deal with adverse events that are more likely in this than the general population.
How Could WeFacilitate Remote Prehabilitation?
Remote prehabilitation removes any space or human resource requirement from healthcare providers, and it is scalable across a population at limited cost. However, adherence rates fall from >95% in hospital-based (supervised) prehabilitation inter­ventions to 70% in remote unsupervised prehabilitation [31]. Compliance is a major determinant of the success, and the protocol should be similarly tailored to the patient’s aerobic tness, lifestyle, and personal preferences where appropriate [32]. It is also critical that some level of supervision is maintained throughout any inter­vention, to maximise adherence [32].
We can learn a lot from the space industry where exercise and nutrition interven­tions, and medical care, have been delivered remotely since 1971, onboard a space station, the Soviet Union’s Salyut [33]. Two basic principles from spaceight mis­sions and telemedicine can be adopted for remote Prehabilitation: gastrointestinal cancer surgery: (1) health screening and (2) remote monitoring and communication.
Principles ofTelehealth
High-risk participants may not be suitable for a remote intervention where medical help may not immediately be at hand. These might include cases with frailty who are at high risk of falls [34] but also cardiovascular abnormalities such as atrial brillation, where exercise might pose a threat of a signicant adverse event, or those with a V O 18mL/min/kg [35]. Remote supervision can also be highly relevant. Depending on the patient and the intervention, this may need to be real-time monitoring of heart
peak (highest amount of oxygen consumed during exercise)
2
76
https://t.me/med1917
rate or ECG.It could encompass the delivery of exercise interventions over web­based video platforms, or online consultations with psychotherapists. A key tenet of remote interventions is that participants do not feel they are left to do things com­pletely independently, as we know this negatively affects compliance with interven­tions and ultimately leads to high attrition rates [36].
The advent of new healthcare technologies (wearable devices) could be used to monitor the health of participants whilst exercising and advise the participant to adjust their effort accordingly.
J. Lambert et al.
How Can WeHarness New Technologies toFacilitate Remote Prehabilitation?
The window between diagnosis and surgical treatment presents a unique opportu­nity where patients are more engaged and motivated for positive behaviour change, to maximise their health outcomes [37]. However, large scale implementation of prehabilitation is challenging due to the gap that currently exists between the resources and demands of healthcare services [38]. The use of digital technologies, so-called telehealth or telemedicine forms part of a solution to this problem, to deliver prehabilitation in a sustainable and efcient way [39]. Engagement in a patient’s own treatment has been shown to improve patient outcomes [40] and home-based prehabilitation can be used to empower patients to play an active role in their treatment pre-surgery.
One of our own prehabilitation studies (SPECS, NCT04880772) employed a remote prehabilitation intervention as the study was started during the pandemic. The delivery of the exercise prehabilitation classes remotely over a web-based plat­form removed the need for patients (typically clinically vulnerable) to enter an envi­ronment with known coronavirus infections during the pandemic, thus reducing the risk of the prehabilitation offer. COVID-19 has accelerated the uptake of technology­based interventions and revolutionised patient care, certainly in primary care where 30% of appointments currently take place remotely, accounting for some 7.4 mil­lion appointments in the UK every year [41].
Limitations toWidespread Adoption ofPrehabilitation
Such include patient access in remote areas, those of low socio-economic status who perhaps cannot afford frequent transport costs to and from a rehabilitation cen­tre, and the nite time available with challenges of work, family-life, and other medical appointments in the run up towards surgery [42]. Technology-based preha­bilitation can circumvent these limitations, thus increasing accessibility to preha­bilitation and potentially reducing health inequalities.
5 Prehabilitation forGastrointestinal Cancer Surgery
https://t.me/med1917
Technologies can be app-based; web-based; video or game digital-based tech­nology; and virtual reality [42]. Smart watches and mobile phone apps can be used both in the delivery of a prehabilitation intervention and in monitoring uptake and adherence of any intervention [43]. Evidence from a recent pilot study suggests that commercially available smart watches and associated apps can increase the volume of moderate and vigorous physical activity that patients undertake, and this results in an increase in functional capacity when measured by the 6-min walk test [43].
A major challenge to the implementation of any technology-based prehabilita­tion is the paucity of high-quality research on their efcacy. In a recent review of 11 RCTs, none measured complication rates, length of hospital stays, or readmission rates [39]. The psychosocial improvements of telehealth interventions appear the most well-documented, with increased return to work, reduction in pain catastroph­ising, and an improved perception of preparedness for surgery [39].
77
Should All Gastrointestinal Cancer Patients BeEnrolled?
From a biological disease point of view, we have not found any factors that preclude participation in prehabilitation, for any modality of gastrointestinal cancer. Time to cancer diagnosis and survivability have been viewed as quality measures of how well or poorly healthcare systems are functioning including the NHS (NHS England and NHS Improvement 2022). The concept of fast-track surgery is now common­place in some units with highly selective patient criteria. This may present a chal­lenge for prehabilitation services due to obvious time constraints.
Within the context of nancial pressures the highest risk patients should be pri­oritized, in whom prehabilitation is likely to benet the most. Strategically used available resources may seamlessly yield results provided that primary, secondary, social care systems can be integrated through better arrangements, data manage­ment, and use of healthcare technology. A useful starting point could be simply a reorganisation of patient treatment pathways where high-risk groups could be iden­tied at primary care levels and referred to a prehabilitation service as a matter of course, like the way patients are referred as 2-week wait referrals for a new cancer diagnosis.
What are theOutcomes ofPrehabilitation?
We have shown that there is a signicant but modest reduction of length stay by
1.8days in hepatobiliary, colorectal, and upper gastrointestinal cancer surgery [2]. Larger cohorts and longer follow ups may be needed. If morbidity and mortality are no different within a year of surgery, does this truly mean there is no effect longer-term?
78
https://t.me/med1917
J. Lambert et al.
Prehabilitation programmes are effective at improving exercise capacity both before and after gastrointestinal cancer surgery. A meta-analysis demonstrated that 6-min walking distance was improved by 33m before surgery and 48m 4–8weeks after surgery [44]. However, no difference in Clavien-Dindo III complication rates was found. Additional studies have reported no effect on postoperative compli­cations, hospital readmissions, mortality, and even hospital length of stay [45], though this latter result contrasts with our own [2].
References
1. Huang GH, Ismail H, Murnane A, etal. Structured exercise program prior to major cancer surgery improves cardiopulmonary tness: a retrospective cohort study. Supp Care Cancer. 2016;24:2277–85.
2. Lambert JE, Hayes LD, Keegan TJ, etal. The impact of Prehabilitation on patient outcomes in hepatobiliary, colorectal, and upper gastrointestinal cancer surgery: a PRISMA-accordant meta-analysis. Ann Surg. 2021;274:70–7.
3. An D, Ayob F, Rajaleelan W, etal. Preoperative smoking cessation as part of surgical preha­bilitation. Can J Anesth. 2019;66:476–9.
4. van Rooijen S, Carli F, Dalton SO, et al. Preoperative modiable risk factors in colorectal surgery: an observational cohort study identifying the possible value of prehabilitation. Acta Oncol (Madr). 2017;56:329–34.
5. Minnella EM, Bousquet-Dion G, Awasthi R, etal. Multimodal prehabilitation improves func­tional capacity before and after colorectal surgery for cancer: a ve-year research experience. Acta Oncol (Madr). 2017;56:295–300.
6. Hassinger TE, Mehaffey JH, Martin AN, etal. Implementation of an enhanced recovery pro­tocol is associated with on-time initiation of adjuvant chemotherapy in colorectal cancer. Dis Colon Rectum. 2019;62:1305–15.
7. Timmons JA, Knudsen S, Rankinen T, etal. Using molecular classication to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol. 2010;108:1487–96.
8. Carli F, Charlebois P, Stein B, etal. Randomized clinical trial of prehabilitation in colorectal surgery. Br J Surg. 2010;97:1187–97.
9. Vergara-Fernandez O, Trejo-Avila M, Salgado-Nesme N.Sarcopenia in patients with colorec­tal cancer: a comprehensive review. World J Clin Cases. 2020;8:1188–202.
10. Wang H, Yang R, Xu J, etal. Sarcopenia as a predictor of postoperative risk of complications, mortality and length of stay following gastrointestinal oncological surgery. Ann Roy Col Surg Eng. 2021;103:630–7.
11. Landskron G, De La Fuente M, Thuwajit P, etal. Chronic inammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185.
12. Gleeson M, Bishop NC, Stensel DJ, etal. The anti-inammatory effects of exercise: mech­anisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011;11:607–15.
13. Mandolesi L, Polverino A, Montuori S, etal. Effects of physical exercise on cognitive func­tioning and wellbeing: biological and psychological benets. Front Psychol. 2018;9:509.
14. Roberts KJ, Schrem H, Hodson J, etal. Pancreas exocrine replacement therapy is associ­ated with increased survival following pancreatoduodenectomy for periampullary malignancy. HPB. 2017;19:859–67.
15. Peterson SJ, Mozer M.Differentiating sarcopenia and cachexia among patients with cancer. Nutr Clin Pract. 2017;32(1):30–9.
5 Prehabilitation forGastrointestinal Cancer Surgery
https://t.me/med1917
16. Gillis C, Buhler K, Bresee L, etal. Effects of nutritional Prehabilitation, with and without exercise, on outcomes of patients who undergo colorectal surgery: a systematic review and meta-analysis. Gastroenterol. 2018;155:391–410.e4.
17. Minnella EM, Awasthi R, Loiselle SE, etal. Effect of exercise and nutrition Prehabilitation on functional capacity in Esophagogastric cancer surgery: a randomized clinical trial. JAMA Surg. 2018;153:1081–9.
18. Mazzola M, Bertoglio C, Boniardi M, et al. Frailty in major oncologic surgery of upper gastrointestinal tract: how to improve postoperative outcomes. Eur J Surg Oncol. 2017;43:1566–71.
19. Nakajima H, Yokoyama Y, Inoue T, etal. Clinical benet of preoperative exercise and nutri­tional therapy for patients undergoing Hepato-Pancreato-biliary surgeries for malignancy. Ann Surg Oncol. 2019;26:264–72.
20. Bousquet-Dion G, Awasthi R, Loiselle SÈ, etal. Evaluation of supervised multimodal preha­bilitation programme in cancer patients undergoing colorectal resection: a randomized control trial. Acta Oncol. 2018;57:849–59.
21. Chen BP, Awasthi R, Sweet SN, etal. Four-week prehabilitation program is sufcient to mod­ify exercise behaviors and improve preoperative functional walking capacity in patients with colorectal cancer. Supp Care Cancer. 2017;25:33–40.
22. Seiler A, Jenewein J.Resilience in Cancer Patients. Front. Psychiatry. 2019;10:208.
23. Jung KH, Kim SM, Choi MG, etal. Preoperative smoking cessation can reduce postoperative complications in gastric cancer surgery. Gastric Cancer. 2015;18:683–90.
24. Lambert J, Mair T, Arujunan K, et al. The effect of the enhanced recovery programme on long-term survival following liver resection for colorectal liver metastases. Langenbeck's Arch Surg. 2023;408:239.
25. Faithfull S, Turner L, Poole K, etal. Prehabilitation for adults diagnosed with cancer: a sys­tematic review of long-term physical function, nutrition and patient-reported outcomes. Eur J Cancer Care. 2019;28:e13023.
26. Dunne DFJ, Jack S, Jones RP, etal. Randomized clinical trial of prehabilitation before planned liver resection. Br J Surg. 2016;103:504–12.
27. Loughney L, West MA, Kemp GJ, etal. The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical tness and quality of life inlocally advanced rectal cancer patients (the EMPOWER trial): study protocol for a randomised con­trolled trial. Trials. 2016;17:24.
28. WHO. Ageing and health. 2022. who.int/news- room/fact- sheets/detail/ageing- and- health. Accessed 28 Jun 2023.
29. Royal College of Surgeons of England. NHS waiting list at record high of over 7.3 mil­lion. 2023.
march- 2023. Accessed 28 Jun 2023.
30. Moore J, Merchant Z, Rowlinson K, etal. Implementing a system-wide cancer prehabilita­tion programme: The journey of greater Manchester’s ‘Prehab4cancer'. Eur J Surg Oncol. 2021;47:524–32.
31. Thomas G, Tahir MR, Bongers BC, et al. Prehabilitation before major intra-abdominal cancer surgery: a systematic review of randomised controlled trials. Eur J Anaesthesiol. 2019;36(12):933–45.
32. Beck A, Vind Thaysen H, Hasselholt Soegaard C, etal. What matters to you? An investigation of patients’ perspectives on and acceptability of prehabilitation in major cancer surgery. Eur J Cancer Care (Engl). 2021;30:e13475.
33. Gaffney CJ, Etheridge T, Szewczyk NJ.Minimizing muscle atrophy. In: Shayler DJ, Seedhouse E, editors. Handbook of life support Systems for Spacecraft and Extraterrestrial Habitats. Heidelberg: Springer; 2020. p.1–27.
34. Michalik C, Maciukiewicz P, Drewa T, etal. Frailty, geriatric assessment and prehabilitation in elderly patients undergoing urological surgery—is there a need for change of the daily clinical practice? Synthesis of the available literature. Cent European J Urol. 2020;73:220–5.
rcseng.ac.uk/news- and- events/media- centre/press- releases/rtt- waiting- times-
79